Table 2.
Sex Differences in Risk of Mortality and/or Hospitalization in Heart Failure with Preserved Ejection Fraction
Study | Endpoint | Risk (95% CI) | |
---|---|---|---|
Women | Men | ||
ARNI | |||
PARAGON-HF91 | CV Mortality or HF Hospitalization | RR 0.73 (0.59–0.90) | RR 1.03 (0.85–1.25) |
Aldosterone blockers | |||
TOPCAT90 | CV Mortality or HF hospitalization | aHR 0.81 (0.63–1.05) | aHR 0.85(0.67–1.08) |
SGLT2 inhibitors | |||
EMPEROR-Preserved94 | CV Mortality or HF hospitalization | HR 0.75 (0.61–0.92) | HR 0.81 (0.69–0.96) |